The Pharmaceutical Market : Chile

By Author: Bharat Book Bureau
Total Articles: 1486
Comment this article

In July 2011, the Institute of Public Health in Chile (ISPCH – Instituto de Salud Pública de Chile) confirmed that it had sent a project to create a National Medicines Agency (ANAMED – Agencia Nacional de Medicamentos) to the Congress for approval. The new agency is expected to update the regulation of medicines, strengthen ISPCH’s regulatory functions and implement a number of measures to increase the competitiveness of the pharmaceutical industry. The creation of ANAMED is part of President Sebastián Piñera’s National Policy of Medicaments that aims to ensure that medicaments sold in Chile meet efficacy, safety and equivalence standards. The industry believes that the creation of ANAMED could speed up the pharmaceutical registration process. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/the-pharmaceutical-market-chile.html

The Chilean pharmaceutical market is expected to increase by a moderate CAGR in US dollar terms between 2011 and 2016. Chile will be the third smallest pharmaceutical market in the region in 2016, after Cuba and Peru. In per capita expenditure terms, ...
... Chile will rank sixth in 2016. Cheap prices and copycat & generic competition are likely to contain the market in local currency terms in the forecast period. In September 2011, the Ministry of Health reported that it had signed an agreement with PAHO/WHO to acquire drugs via the Strategic Fund, also known as the Regional Revolving Fund for Strategic Public Health Supplies.

Laboratorio Chile, Recalcine, Andrómaco, Saval and Bagó are the leading companies. Laboratorio Chile forms part of the Teva group. Recalcine forms part of Corporación Farmacéutica Recalcine (CFR), which launched an IPO in the Chilean Stock Exchange in May 2011. CFR acquired a 50.8% shareholding in the Canadian Uman and a 41.9% shareholding in the Vietnamese Domesco in November 2011. Andrómaco and Saval remain in local hands, whilst Bagó is the subsidiary of the Argentine Bagó group. Some local producers have been acquired in recent years; the Brazilian Eufofarma acquired Volta and Farmaindustria in December 2010; the Spanish subsidiary of the Italian pharmaceutical company Italfarmaco acquired Labomed in July 2009, and the German Fresenius Kabi acquired Sanderson in 2007.

Espicom's highly-regarded world pharmaceutical market research reports provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

Market size and trends impacting the development of the market.
Five-year projections for market indicators such as health spending.
Regulations on drug applications & approvals, pricing & reimbursement as well as wholesaling and retail.
Specialised intelligence on generics and biological medicines.
Foreign and local company profiles
EXECUTIVE SUMMARY 1
Snapshot: Strategic Espicom Analysis2
Snapshot: Key Data Projections 3
MACROENVIRONMENT 4
POLITICAL4
ECONOMIC5
Projections5
LEGAL6
National Institute for Industrial Property6
Intellectual Property Rights6
Customs IP Co-operation Agreement6
Antitrust Activities6
DEMOGRAPHIC7
Projections 7
Demographic Indicators8
Birth Rate 8
Death Rate 8
Infant Mortality 8
Life Expectancy at Birth 8
EPIDEMIOLOGY 9
DISEASE BURDEN9
DISEASE PREVALENCE9
Communicable Diseases9
HIV/AIDS 9
Non-Communicable Diseases9
HEALTHCARE - ACCOMPANYING HEALTH STATISTICS 10
ORGANISATION10
Isapres10
SNSS/FONASA12
REFORM 13
Financing Government Expenditure Law14
Health Authority & Management Law14
Health Guarantees System Law 14
Private Health Amendment Law15
People’s Rights & Duties Law15
EXPENDITURE16
Projections16
Health Insurance17
INFRASTRUCTURE18
Inpatient Resources18
Outpatient Resources18
SERVICES18
Inpatient Services18
Outpatient Services18
WORKFORCE19
Projections19
Latest Figures20
REGULATORY AFFAIRS 21
NATIONAL REGULATORY BODIES21
ANAMED21
ISPCH21
PHARMACEUTICAL REGISTRATION 22
Product Registrations22
GMP Standards22
Pharmacovigilance22
ARMs22
Complaints22
Stock Control23
Bioequivalence23
PROMOTION24
Advertising24
PRICING & REIMBURSEMENT 25
PRICING 25
Public Procurement25
CENABAST25
ChileCompra25
Strategic Fund25
REIMBURSEMENT26
DISTRIBUTION CHANNELS 27
WHOLESALING27
Wholesalers27
Drogueria Ñuñoa27
SOCOFAR27
RETAILING 28
Pharmacy Associations28
Pharmacy Chains29
Farmacias Ahumada29
Farmacias Cruz Verde29
Farmacias Salcobrand30
MARKET ANALYSIS 31
SIZE31
Projections31
Historical Figures33
Structure34
PRODUCT DEVELOPMENT35
PRODUCTION 36
TRADE39
Exports39
Imports41
Balance of Trade46
COMPETITION 47
TRADE ASSOCIATIONS47
ASILFA 47
CANALAB 47
CIF48
COMPANY INTELLIGENCE 49
Foreign Producers49
Bagó49
Fresenius Kabi – Sanderson49
Italfarmaco – Labomed50
Teva - Laboratorio Chile50
Local Producers51
Andrómaco 51
Instituto Sanitas 53
Recalcine 53
Saval54
Competitive Strategies55
OTC PHARMACEUTICALS 56
MARKET SIZE 56
COMPETITION 56
Trade Association56
CAMEVED56
Company Intelligence56
Maver56
GENERIC PHARMACEUTICALS 57
REGULATORY AFFAIRS57
Bioequivalence57
MARKET SIZE57
COMPETITION 58
Company Intelligence58
Andrómaco58
Biosano58
Mintlab59
For more information kindly visit :
The Pharmaceutical Market : Chile

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: https://twitter.com/BharatBook
Our Blogs: http://in.linkedin.com/pub/bharat-book/3a/98/512
http://financemarketreports.blogspot.com/